Challenges include high costs and limited diagnosis, but opportunities for growth lie in gene therapy commercialization, expanded screening, and emerging marketsDublin, April 21, 2026 (GLOBE NEWSWIRE) ...
CAMBRIDGE, England--(BUSINESS WIRE)--Cambridge GaN Devices (CGD), the fabless, clean-tech semiconductor company that develops energy-efficient GaN-based power devices that make greener electronics ...
X-linked chronic granulomatous disease (X-CGD) is a rare genetic disorder characterized by high susceptibility to infections that results from genetic mutations in the cytochrome b-245 beta chain ...
Chronic granulomatous disease (CGD) describes an inherited genetic condition that affects a person’s immune system. It results in a type of immunodeficiency and causes people to be highly susceptible ...
"Wide-bandgap semiconductors like GaN and SiC are being integrated into motor control applications for the power density and efficiency advantages they offer. CGD's ICeGaN technology delivers ease of ...
Most of the patients with CGD present during the first 5 years of life. The most commonly involved organs are: skin, lungs, GI tract, lymph nodes, liver, and spleen. An early onset of severe recurrent ...
CAMBRIDGE, England--(BUSINESS WIRE)--Cambridge GaN Devices (CGD), the fabless, clean-tech semiconductor company that develops a range of energy-efficient GaN-based power devices to make greener ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results